WebMD: Better information. Better health.
    Logo for WebMD
    • Check Your Symptoms
    • Find A Doctor
    • Health A-Z
    • Drugs & Supplements
    • Living & Healthy
    • Family & Pregnancy
    • News & Experts
    • Subscriptions

    • Lung Cancer
    • Understanding EGFR Mutations in Non-Small-Cell Lung Cancer

    How EGFR-Positive Lung Cancer Is Treated

      Next
      Article

      Therapies and Treatments to Consider

      Some non-small-cell lung cancers (NSCLC) have changes in a gene called EGFR. If your NSCLC has these mutations, your doctor likely will recommend treatment with targeted therapies that block EGFR. Learn what you should know about your treatment options and outlook.

      Explore More
      Infographic

      Which Demographics Are More at Risk?

      Who’s most at risk for getting EGFR-positive lung cancer? Learn which factors increase your chances.

      Article

      Exploring Clinical Trials

      You’ll have more treatment options for EGFR-positive non-small-cell lung cancer (NSCLC) now than ever before. But doctors are still testing new treatments and combinations in clinical trials. Find out if a clinical trial may be an option for you.

      Article

      EGFR Mutations Defined

      What are epidermal growth factor receptor (EGFR) mutations? Learn more about their biology, formation, and impact on lung cancer.

      Video

      What is EGFR-Positive Lung Cancer?

      This subtype occurs in 10% to 15% of cases and is more common in people who have never smoked. What are the causes and symptoms?

      See More on Lung Cancer From WebMD

      Go Now >
      • About WebMD
      • Advertise With Us
      • Terms of Use
      • Privacy Policy
      • Cookie Policy
      • Editorial Policy
      • Contact Us
      • AdChoice
      • TRUSTe Privacy Certification
      • TAG Registered Seal
      • HONcode Seal

      ©2005-2023 WebMD LLC. All rights reserved. WebMD does not provide medical advice, diagnosis or treatment. See additional information.